ANO1 and neoplasm: ANO1's positive rate was higher in nonresponders (52.9%, 9/17) than responders (35.5%, 11/31) (Figure 1E), while ANO1‐negative cases displayed more favorable dynamic changes of tumor volume (Figure 1F) and the best changes of tumor volume (Figure 1G) than ANO1‐positive cases.